Effect of Administering Short-Course, Standardized Regimens in Individuals Infected with Drug-Resistant Mycobacterium tuberculosis Strains

被引:0
|
作者
J. J. Furin
M. C. Becerra
S. S. Shin
J. Y. Kim
J. Bayona
P. E. Farmer
机构
[1] Department of Social Medicine,
[2] Harvard Medical School,undefined
[3] 641 Huntington Avenue,undefined
[4] Boston,undefined
[5] MA 02115,undefined
[6] USA e-mail: JENFURIN@AOL.COM,undefined
[7] Department of Epidemiology,undefined
[8] Harvard School of Public Health,undefined
[9] Boston,undefined
[10] MA,undefined
[11] USA,undefined
[12] Socios En Salud,undefined
[13] Sucursal,undefined
[14] Lima,undefined
[15] Peru,undefined
来源
European Journal of Clinical Microbiology and Infectious Diseases | 2000年 / 19卷
关键词
Tuberculosis; Standard Treatment; Mycobacterium Tuberculosis; Standard Regimen; Susceptibility Pattern;
D O I
暂无
中图分类号
学科分类号
摘要
 Presented here are the cases of three siblings with multidrug-resistant tuberculosis who demonstrated increased antituberculous-drug resistance during the periods in which they received standard regimens of directly observed, short-course chemotherapy that were administered before the susceptibility patterns of their Mycobacterium tuberculosis isolates had been checked. More specifically, they acquired resistance to drugs they received as part of ineffective standard treatment and retreatment regimens. Development of antituberculous-drug resistance through inadvertent, inadequate therapy appears to be the most likely explanation for the increased resistance seen in these three patients.
引用
收藏
页码:132 / 136
页数:4
相关论文
共 50 条
  • [21] Molecular Characteristic of Both Levofloxacin and Moxifloxacin Resistance in Mycobacterium tuberculosis from Individuals Diagnosed with Preextensive Drug-Resistant Tuberculosis
    Zhang, Xiaofu
    Chen, Xi
    Wang, Bin
    Fu, Lei
    Huo, Fengmin
    Gao, Tianhui
    Pang, Yu
    Lu, Yu
    Li, Qi
    MICROBIAL DRUG RESISTANCE, 2022, 28 (03) : 280 - 287
  • [22] Case Report: Dynamics of Acquired Fluoroquinolone Resistance under Standardized Short-Course Treatment of Multidrug-Resistant Tuberculosis
    Ngabonziza, Jean Claude Semuto
    Van Deun, Armand
    Migambi, Patrick
    Niyigena, Esdras Belamo
    Dusabe, Theogene
    Habimana, Yves Mucyo
    Ushizimpumu, Bertin
    Mulders, Wim
    Decroo, Tom
    Affolabi, Dissou
    Supply, Philip
    de Jong, Bouke C.
    Rigouts, Leen
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2020, 103 (04) : 1443 - 1446
  • [23] A genome-wide analysis of multidrug-resistant and extensively drug-resistant strains of Mycobacterium tuberculosis Beijing genotype
    Wu, Wei
    Zheng, Huajun
    Zhang, Lu
    Wen, Zilu
    Zhang, Shulin
    Pei, Hao
    Yu, Guohua
    Zhu, Yongqiang
    Cui, Zhenling
    Hu, Zhongyi
    Wang, Honghai
    Li, Yao
    MOLECULAR GENETICS AND GENOMICS, 2013, 288 (09) : 425 - 436
  • [24] In vitro inhibition of drug-resistant and drug-sensitive strains of Mycobacterium tuberculosis by ethnobotanically selected South African plants
    Lall, N
    Meyer, JJM
    JOURNAL OF ETHNOPHARMACOLOGY, 1999, 66 (03) : 347 - 354
  • [25] Technique of preventive treatment of children with immunobiological disorders and children infected with drug-resistant strains of tuberculosis mycobacteria
    Luginova, E. F.
    YAKUT MEDICAL JOURNAL, 2007, (01): : 16 - 20
  • [26] Mefloquine and its oxazolidine derivative compound are active against drug-resistant Mycobacterium tuberculosis strains and in a murine model of tuberculosis infection
    Rodrigues-Junior, Valnes S.
    Villela, Anne D.
    Goncalves, Raoni S. B.
    Abbadi, Bruno Lopes
    Trindade, Rogerio Valim
    Lopez-Gavin, Alexandre
    Tudo, Griselda
    Gonzalez-Martin, Julian
    Basso, Luiz Augusto
    de Souza, Marcus V. N.
    Campos, Maria Martha
    Santos, Diogenes Santiago
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2016, 48 (02) : 203 - 207
  • [27] Predicting the Outcomes of New Short-Course Regimens for Multidrug-Resistant Tuberculosis Using Intrahost and Pharmacokinetic-Pharmacodynamic Modeling
    Doan, Tan N.
    Cao, Pengxing
    Emeto, Theophilus I.
    Mccaw, James M.
    McBryde, Emma S.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2018, 62 (12)
  • [28] A Preliminary Study on the Synergistic Effect of Nano Ag and Anti-Tuberculosis Drugs on Drug-Resistant Mycobacterium tuberculosis
    Li, Xiaofei
    Sheng, Lina
    Tu, Juncai
    Lou, Lianqing
    JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY, 2020, 20 (10) : 6155 - 6160
  • [29] Viability, biofilm formation, and MazEF expression in drug-sensitive and drug-resistant Mycobacterium tuberculosis strains circulating in Xinjiang, China
    Zhao, Ji-Li
    Liu, Wei
    Xie, Wan-Ying
    Cao, Xu-Dong
    Yuan, Li
    INFECTION AND DRUG RESISTANCE, 2018, 11 : 345 - 358
  • [30] Drug-resistant Tuberculosis: First Line Drug Resistance Pattern among Mycobacterium tuberculosis Strains Isolated from a Reference Laboratory in Kerala State, India
    Murthy, Neetha S.
    Nair, Sanjeev
    Ramya, P. K.
    George, Renu Susan
    Ravikrishnan, B.
    Kumar, M. Sunil
    Philip, Sairu
    Rakesh, P. S.
    Balakrishnan, Shibu
    JOURNAL OF PURE AND APPLIED MICROBIOLOGY, 2021, 15 (04) : 1882 - 1891